What is a 'blackout period' in this context?

A 'blackout period' is a temporary restriction placed on trading company stock by directors and executive officers. In this case, it's triggered by a significant number of participants in Johnson & Johnson's employee benefit plans electing to exchange their company shares, and it's a regulatory requirement under the Sarbanes-Oxley Act (SOX) and Regulation BTR.

Who is affected by this blackout period?

The blackout period primarily affects Johnson & Johnson's directors and executive officers. It also impacts participants in JNJ's employee stock plans (like the Savings Plan and Retirement Savings Plan) if they choose to tender their JNJ shares held within those plans for the Kenvue exchange offer, as their ability to trade or move those specific assets will be temporarily suspended.

Does this blackout period affect all JNJ shareholders?

No, this blackout period specifically targets directors and executive officers of Johnson & Johnson and, indirectly, participants in certain employee stock plans who elect to participate in the Kenvue exchange offer. It does not impose trading restrictions on the general public or other JNJ shareholders.

What is the significance of the Kenvue Inc. share exchange offer mentioned?

The Kenvue Inc. share exchange offer is a major event where Johnson & Johnson is offering to exchange a substantial number of its Kenvue shares for its own outstanding common stock. This blackout period is a consequence of the mechanics and regulatory implications of this large-scale exchange involving employee benefit plans.

JNJ 8-K SEC Disclosure — Jul 28, 2023

Summary

Johnson & Johnson (JNJ) has filed an 8-K report on July 28, 2023, to disclose a potential temporary trading suspension, commonly known as a "blackout period," for its directors and executive officers. This is in connection with the company's ongoing offer to exchange a significant portion of its Kenvue Inc. common stock for outstanding Johnson & Johnson shares. The blackout period is triggered if 50% or more of the participants in JNJ's employee benefit plans elect to tender their JNJ shares held within the company's stock fund as part of the Kenvue exchange offer. This is a regulatory requirement under Sarbanes-Oxley Act and Regulation BTR, aimed at restricting insider trading during certain corporate events that could affect employee benefit plans. If imposed, the blackout period is expected to commence around August 15, 2023, and last through the week of August 28, 2023, assuming the Kenvue exchange offer does not extend. During this time, JNJ's directors and officers will be restricted from buying or selling JNJ securities, with limited exemptions, though they will still have the opportunity to participate in the Kenvue exchange offer. Investors should note that this event primarily impacts insider trading and employee benefit plan participants, rather than the company's ongoing business operations or financial performance, but it signals a significant step in the Kenvue divestiture process.

Key Highlights

1Johnson & Johnson (JNJ) announced a potential blackout period for its directors and executive officers.
2The blackout is linked to JNJ's offer to exchange its Kenvue Inc. shares for JNJ common stock.
3A 50% participation threshold in employee stock plans dictates the imposition of the blackout.
4The potential blackout period is expected to start around August 15, 2023, and last through the week of August 28, 2023.
5During the blackout, directors and officers will face restrictions on trading JNJ securities, except for participating in the Kenvue exchange offer.
6This action is a regulatory compliance measure under the Sarbanes-Oxley Act (SOX) and Regulation BTR.

JOHNSON & JOHNSON 8-K Report, Temporary Suspension of Trading Under Employee Benefit Plans (Jul 28, 2023)

Summary

Key Highlights

Frequently Asked Questions